Wnt-11 Activators
The category of Wnt-11 activators constitutes a diverse spectrum of chemicals intricately designed to modulate the activity of Wnt-11 through various signaling pathways. These compounds not only shed light on the regulatory mechanisms dictating Wnt-11 function but also highlight the intricate interplay within cellular processes, including Wnt/β-catenin signaling, GSK-3 inhibition, and LRP5/6 receptor activation, all contributing to the orchestration of Wnt-11 activation. One pivotal aspect of these activators lies in their ability to directly activate Wnt-11, emphasizing the intricate and multifaceted regulatory network governing this particular protein. This direct activation serves as a testament to the complexity of the underlying molecular processes that dictate Wnt-11 function. Furthermore, the recognition of Wnt-11 as a key player in cellular regulation extends beyond the canonical Wnt signaling pathway, with these activators offering interventions into a broader array of cellular processes.
The interconnectedness of Wnt/β-catenin signaling, GSK-3 inhibition, and LRP5/6 receptor activation underscores the sophistication of these activators in influencing Wnt-11 activity. By understanding the specific biochemical and cellular pathways impacted by these activators, researchers gain valuable insights into the nuanced modulation of Wnt-11. This enhanced comprehension not only deepens our understanding of Wnt-11 function but also opens new avenues for further exploration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
By inhibiting GSK-3, CHIR99021 prevents the degradation of β-catenin, a key component of the Wnt pathway. This leads to the stabilization and accumulation of β-catenin in the cytoplasm, facilitating its translocation into the nucleus. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride indirectly activates Wnt-11 through inhibition of GSK-3β. GSK-3β is a negative regulator of the Wnt pathway, and lithium chloride inhibits GSK-3β activity, promoting the stabilization of β-catenin. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO is a GSK-3 inhibitor that influences Wnt signaling. By inhibiting GSK-3, BIO prevents the degradation of β-catenin, leading to its stabilization and nuclear translocation. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 is a small molecule inhibitor of Porcupine, a crucial enzyme for Wnt secretion. By blocking Wnt production, Wnt-C59 indirectly influences Wnt-11 activity. This inhibitor disrupts the availability of Wnt ligands, impacting the cellular milieu and potentially attenuating the activation of Wnt-11. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV939 is a tankyrase inhibitor that modulates Wnt signaling. By inhibiting tankyrase, XAV939 stabilizes Axin, a key component of the β-catenin destruction complex. This stabilization enhances the activity of the destruction complex, leading to increased degradation of β-catenin. | ||||||
WAY 262611 | sc-397019 sc-397019A | 5 mg 25 mg | $131.00 $520.00 | 2 | ||
WAY-262611 is a small molecule activator of Wnt signaling. By targeting the LRP5/6 receptors, WAY-262611 enhances Wnt signaling and the downstream cascade. This direct activation of Wnt signaling pathways may lead to the modulation of Wnt-11 activity, as the Wnt pathway components are interconnected. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 is a small molecule inhibitor of Wnt/β-catenin signaling. By disrupting the interaction between β-catenin and TCF, KY02111 inhibits the transcriptional activity of β-catenin. This inhibition indirectly influences Wnt-11 activity, as the Wnt/β-catenin signaling pathway components are interconnected. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1-endo is a small molecule inhibitor of the Wnt/β-catenin pathway. By promoting the degradation of β-catenin, IWR-1-endo inhibits Wnt signaling. This inhibition indirectly impacts Wnt-11 activity, as the Wnt/β-catenin signaling pathway components are interconnected. IWR-1-endo's promotion of β-catenin degradation contributes to the potential modulation of Wnt-11 through intricate regulatory mechanisms within the Wnt/β-catenin signaling cascade. | ||||||